The relationship between genes affecting the development of epilepsy and approaches to epilepsy therapy.

Abstract excerpt

The epilepsies are a clinically heterogeneous group of common brain diseases which are refractory to pharmacotherapy in up to one-third of patients. The discovery of DNA variants that cause or predispose to epilepsy has the potential to lead to new treatments that are based on the protein products or functional pathways of implicated genes. Overlap of gene classes involved in several broad phenotypic categories...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Epilepsy
• Share to Genetic Predisposition to Disease